Lex­eo Ther­a­peu­tics joins small class of 2023 biotech IPOs in $100M Nas­daq list­ing

Lex­eo Ther­a­peu­tics will be­gin trad­ing on the Nas­daq on Fri­day morn­ing via a $100 mil­lion ini­tial pub­lic of­fer­ing.

The car­diac and Alzheimer’s gene ther­a­py biotech …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.